Medical, Health, & Pharmacy News Headlines

Pharmacy News Archives

Medical News Today
EurekAlert!
Univ. of Maryland
Medbroadcast.com
Reuters Health/Medical
New York Times Health
BBC Health & Medical
PRWeb Pharmaceuticals

Popular Medications

Weight Loss & Diet
Pain Relief
Men's Health
Women's Health
Skin Care
Quit Smoking
Sexual Health
Muscle Relaxants
Allergy Relief
Anti-depressants
Anxiety
Sleep Aids
Gastro-intestinal

Insurance & Litigation

Viatical Settlement

Tools & Information

Currency Converter
Resource Directory
Pharmacy Affiliate

 Back to Medical News Today Archives



Medical News Today: 02-27-2005

Ranbaxy Receives Tentative Approval To Market Donepezil Hydrochloride Tablets
New Delhi - Ranbaxy Laboratories Limited (RLL) announced today that the Company has received tentative approval from the U... click link for more info.

HDA Comment on the ONS report on healthy life expectancy and deprivation, UK
Professor Mike Kelly, Director of Evidence and Guidance for the Health Development Agency said: "Longer, healthier lives for the rich; shorter, unhealthier lives for the poor: the ONS report focuses much needed attention on the stark impact of health inequalities... click link for more info.

Program to Take Psychiatric Services to Frail Elderly in Their Homes
A groundbreaking outreach program for frail elderly who need psychiatric services in their homes - believed to be the first of its kind in the United States -- is being launched by the Department of Psychiatry and Behavioral Medicine at Wake Forest University Baptist Medical Center... click link for more info.

California's Emergency Medical Response Systems in Crisis
Ninety-percent of California communities' emergency medical services response and patient transport falls to private ambulance operations during a natural disaster, act of terrorism or other large scale incident... click link for more info.

Individual Guidelines Determine Frequency of Colonoscopy
March is Colorectal Cancer Awareness Month - People know to get their cars tuned up every 10,000 miles, change the batteries in the smoke detector once a year and rotate their mattress every month or two... click link for more info.

Gilead Gains European Approval To Market Combination Antiretroviral Drug Truvada
Foster City, Calif... click link for more info.

Nigerian Government Hopes To Provide Low-Cost Antiretroviral Drugs to 100,000 People This Year
Nigerian Health Minister Eyitayo Lambo on Wednesday announced that the government plans to expand its antiretroviral drug program to provide low-cost drugs to 100,000 HIV-positive people by the end of this year,... click link for more info.

Protecting your skin from ageing - Simple Tips to Looking Good At Every Age
Warmer weather will soon be here and that means spending more time in the sun's dangerous rays, which cause about 85 percent of premature aging... click link for more info.

Researchers Still Divided Over Significance of New York City Case of Rare, Drug-Resistant HIV Strain
Experts on Thursday at the... click link for more info.

Botswana, Barbados Agree To Cooperate To Exchange HIV/AIDS Expertise, Research
Botswana President Festus Mogae and Barbados Prime Minister Owen Arthur on Wednesday in Bridgetown, Barbados, signed an agreement to cooperate in the fight against HIV/AIDS, the... click link for more info.

Majority of foods contaminated with dye Sudan I removed from sale
The Food Standards Agency (UK) has announced that the vast majority of products contaminated with the illegal dye Sudan I have been removed from sale... click link for more info.

Smith & Nephew Launches Periarticular Locked Plating System to Treat Trauma Patients
Smith & Nephew's Orthopaedics business (NYSE: SNN, LSE: SN) announced the introduction of its PERI-LOC° Periarticular Locked Plating System... click link for more info.

One central point for start-up biopharmaceutical companies: BioConnection
A new center, unique in Europe, will be established in Oss, The Netherlands, providing facilities and expertise for the development and production of new biopharmaceutical medicines... click link for more info.

Merck Issues Statement on Granting of Coordinated Pre-Trial Status For Federal VIOXX® Lawsuits
The federal Judicial Panel on Multidistrict Litigation granted motions by several parties, including Merck, to transfer all VIOXX® shareholder suits pending in federal courts nationwide into one consolidated Multidistrict Litigation (MDL) for coordinated pre-trial proceedings... click link for more info.

Multiple Sclerosis - Tysabri® 2-Year Monotherapy Trial Demonstrates Significant Impact On Disability Progression And Relapse Rate
Data Show 42% Reduction in the Risk of Disability Progression and Sustained 67% Reduction in Relapse Rate - Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today that the Phase III TYSABRI® (natalizumab) AFFIRM monotherapy trial achieved the two-year primary endpoint of slowing the progression of disability in patients with relapsing forms of multiple sclerosis (MS)... click link for more info.

Advisory Panel Discussion points to Aleve®
Members of FDA Committees Support Safety of Naproxen, Active Ingredient in Aleve® - Bayer HealthCare's Consumer Care Division said today it was pleased that discussions by the U... click link for more info.

Kogenate® FS Donated by Bayer Biological Products to World Federation of Hemophilia
Donation Expected to Assist Hundreds of People Living with Hemophilia in 13 Countries - Bayer Healthcare LLC, Biological Products Division (Bayer BP), announced it is donating 2... click link for more info.

FDA Approves Atacand® (Candesartan Cilexetil) for the Treatment of Heart Failure
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) ATACAND® (candesartan cilexetil) for the treatment of heart failure (New York Heart Association Class II-IV and ejection fraction less than or equal to 40 percent) to reduce the risk of death from cardiovascular causes and reduce hospitalisations from heart failure... click link for more info.

Neulasta Significantly Lowers Incidence of Neutropenia with Related Fever and Hospitalization, Phase 3 Study
Amgen Inc announced that data from the largest randomized placebo-controlled study to date for Neulasta(R) (pegfilgrastim) has been published in the February 20 issue of The Journal of Clinical Oncology... click link for more info.

Combination Therapy Might Be Better Choice Than Nevirapine Alone To Prevent Vertical HIV Transmission, Researchers Say
Antiretroviral drug combination therapy might be more effective in preventing mother-to-child HIV transmission and less likely to foster drug resistance among pregnant women than single-dose nevirapine, according to data presented this week at the... click link for more info.

Those at high risk of diabetes know very little about it
People at high risk of diabetes know very little about the condition, delaying diagnosis and leaving them vulnerable to developing serious complications... click link for more info.

Many States Have Inadequate Response Procedures for Bioterrorist, Chemical Attacks, HHS Official Says (USA)
Fewer than 25% of states can respond at all times of the day to hospital alerts about patients who might have experienced bioterrorist or chemical attacks, William Raub,... click link for more info.

Kaiser Daily Health Policy Report Examines Developments Related to Medical Malpractice in Five States, USA
The Kaiser Daily Health Policy Report features recent developments related to medical malpractice insurance in five states... click link for more info.

Florida To Hire Firms To Detail Governor's Medicaid Reform Proposal
The Florida http://www... click link for more info.

Illinois HMO Enrollment Falls Below 2M for First Time in 10 Years
HMO enrollment in Illinois decreased by 6... click link for more info.

Administration Officials Clarify Bush Comments on Legislation To Change Medicare Drug Benefit
Bush administration officials this week sought to address concerns among some conservative Republicans that President Bush would veto any legislation aiming to alter the new Medicare law, ... click link for more info.

CDC To Separate Vaccine Safety Monitoring, National Immunization Programs
... click link for more info.

Zerhouni Defends New NIH Conflict-of-Interest Guidelines
... click link for more info.

Arkansas Senate Passes Bill That Would Require State To Negotiate Discounts on Prescription Drugs for Uninsured
The Arkansas Senate on Wednesday voted 26-4 to approve a... click link for more info.

AARP Launches Prescription Drug Comparison Web Site
... click link for more info.

Two-Thirds of US Residents Support More Regulation of Prescription Drug Prices, Poll Shows
Sixty-five percent of US residents support more federal regulation of prescription drug prices, and 51% support additional regulations on prescription drug advertisements, according to a... click link for more info.

10 Experts on FDA Advisory Panel Supporting COX-2 Inhibitors Had Ties to Pharmaceutical Industry
Almost one-third of the members on the... click link for more info.

S. Dakota House Committee Approves Parental Notification Bill; Senate Committee Approves Three Abortion-Related Bills
The South Dakota House State Affairs Committee on Wednesday approved 10-1 a bill... click link for more info.

Idaho Senate Committee Approves Bill Expanding Family Planning Services Under State CHIP, Medicaid Programs
The Idaho Senate Health and Welfare Committee on Wednesday approved 8-0 a bill... click link for more info.

Georgia House Approves Bill That Would Require 24-Hour Waiting Period for Women Seeking Abortion
The Georgia House on Wednesday voted 139-35 to approve a bill... click link for more info.

NTT Prototypes Technology to Use Human Body As Digital Transmission Path
Tokyo (JCNN) - NTT (TSE: 9432) has developed an innovative human area networking technology called RedTacton (red implies a warm color; tacton is coined with "touch" and "action") that turns the surface of a human body into a data transmission path... click link for more info.

GSI Creos Develops Innovative Cell Culture Incubator Using Cup-stacked Carbon Nanotubes
Tokyo (JCNN) - GSI Creos (TSE: 8101) has announced that it has prototyped Carbere, a new cell culture incubator, using its proprietary cup-stacked-type carbon nanotubes (CSCNT)... click link for more info.

Toray Industries Develops Innovative Plastic and Hypersensitive Chip for Protein Analysis
Tokyo (JCNN) - Toray Indsutries (TSE: 3402) has announced that it has prototyped a plastic chip designed for protein analysis... click link for more info.

Effectiveness of Simultaneous Use of Alpha Lipoic Acid and Amino Acid in Reducing Fat Accumulation, Rohto Pharmaceutical
Tokyo (JCNN) - Rohto Pharmaceutical (TSE: 4527) has announced that the company has discovered an unique property of alpha lipoic acid and amino acid... click link for more info.

Ankle Sprains Show Link to Development of Osteoarthritis
Ankle sprains may predispose a patient to osteoarthritis according to a study presented at the American Orthopaedic Foot and Ankle Society's Annual Winter Meeting in Washington, DC, today... click link for more info.

© Medical News Today